"Lack of clinically significant interference by spironolactone with the Axsym Digoxin II assay" only applies to low-dose therapy with spironolactone.

Titel:: "Lack of clinically significant interference by spironolactone with the Axsym Digoxin II assay" only applies to low-dose therapy with spironolactone.
Dokumenttyp:: Comment; Letter; Letter
Autor(en):: Steimer, W
Zeitschriftentitel:: Ther Drug Monit
Jahr:: 2003
Band / Volume:: 25
Heft / Issue:: 4
Seitenangaben Beitrag:: 484-5
Sprache:: eng
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/12883235
Print-ISSN:: 0163-4356
TUM Einrichtung:: Institut für Klinische Chemie und Pathobiochemie
BibTeX

Vorkommen: